Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 6
2003 4
2004 6
2005 5
2006 8
2007 8
2008 7
2009 11
2010 6
2011 7
2012 7
2013 4
2014 2
2015 2
2017 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
The BMP-2 mutant L51P: a BMP receptor IA binding-deficient inhibitor of noggin.
Khattab HM, Kubota S, Takigawa M, Kuboki T, Sebald W. Khattab HM, et al. Among authors: sebald w. J Bone Miner Metab. 2019 Mar;37(2):199-205. doi: 10.1007/s00774-018-0925-0. Epub 2018 Apr 17. J Bone Miner Metab. 2019. PMID: 29667005 Review.
Utilizing BMP-2 muteins for treatment of multiple myeloma.
Seher A, Lagler C, Stühmer T, Müller-Richter UDA, Kübler AC, Sebald W, Müller TD, Nickel J. Seher A, et al. Among authors: sebald w. PLoS One. 2017 May 10;12(5):e0174884. doi: 10.1371/journal.pone.0174884. eCollection 2017. PLoS One. 2017. PMID: 28489849 Free PMC article.
Intricacies of BMP receptor assembly.
Nickel J, Sebald W, Groppe JC, Mueller TD. Nickel J, et al. Among authors: sebald w. Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):367-77. doi: 10.1016/j.cytogfr.2009.10.022. Cytokine Growth Factor Rev. 2009. PMID: 19926516 Review.
Bone Recuperation After rhBMP-2 Insertion in Alcoholic Animals-Experimental Study.
dos S Kotake BG, Salzedas LM, Ervolino E, Calzzani RA, Sebald W, Issa JP. dos S Kotake BG, et al. Among authors: sebald w. Curr Pharm Des. 2015;21(24):3557-64. doi: 10.2174/1381612821666150428163307. Curr Pharm Des. 2015. PMID: 25925228
GDF-5 can act as a context-dependent BMP-2 antagonist.
Klammert U, Mueller TD, Hellmann TV, Wuerzler KK, Kotzsch A, Schliermann A, Schmitz W, Kuebler AC, Sebald W, Nickel J. Klammert U, et al. Among authors: sebald w. BMC Biol. 2015 Sep 18;13:77. doi: 10.1186/s12915-015-0183-8. BMC Biol. 2015. PMID: 26385096 Free PMC article.
Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
Sebald W, Nickel J, Zhang JL, Mueller TD. Sebald W, et al. Biol Chem. 2004 Aug;385(8):697-710. doi: 10.1515/BC.2004.086. Biol Chem. 2004. PMID: 15449706 Review.
Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
Mueller TD, Zhang JL, Sebald W, Duschl A. Mueller TD, et al. Among authors: sebald w. Biochim Biophys Acta. 2002 Nov 11;1592(3):237-50. doi: 10.1016/s0167-4889(02)00318-x. Biochim Biophys Acta. 2002. PMID: 12421669 Free article. Review.
The interaction of BMP-7 and ActRII implicates a new mode of receptor assembly.
Sebald W, Mueller TD. Sebald W, et al. Trends Biochem Sci. 2003 Oct;28(10):518-21. doi: 10.1016/j.tibs.2003.08.001. Trends Biochem Sci. 2003. PMID: 14559178 Review.
Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.
Whitman M, Rosen V, Brivanlou AH, Groppe JC, Sebald W, Mueller T. Whitman M, et al. Among authors: sebald w. Nat Med. 2013 Jul;19(7):809-10. doi: 10.1038/nm.3080. Nat Med. 2013. PMID: 23836213 No abstract available.
Regeneration of calvarial defects with Escherichia coli -derived rhBMP-2 adsorbed in PLGA membrane.
Ono M, Sonoyama W, Nema K, Hara ES, Oida Y, Pham HT, Yamamoto K, Hirota K, Sugama K, Sebald W, Kuboki T. Ono M, et al. Among authors: sebald w. Cells Tissues Organs. 2013;198(5):367-76. doi: 10.1159/000356947. Epub 2014 Jan 11. Cells Tissues Organs. 2013. PMID: 24434422
73 results
Jump to page